Medical Park Pharmacy Recalls Tadalafil 20 mg Troche Due to Expired Components
MPRX, Inc. dba Medical Park Pharmacy is recalling Tadalafil 20 mg Troche because the products were compounded using expired components and have incorrect or missing lot and expiration dates.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text identifies the issue as labeling errors and the use of expired components without reporting any specific illnesses, injuries, or hospitalizations, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
MPRX, Inc. dba Medical Park Pharmacy is recalling Tadalafil 20 mg Troche. The recall involves 9 bottles of the product distributed in Texas. The specific lots affected are 61137:42 (Use by: 03/08/2020), 61324:99 (Use by: 04/04/2020), and 60856:42 (Use by: 02/02/2020).
The recall was initiated due to labeling issues, specifically incorrect or missing lot and/or expiration dates. Additionally, the source text states that the products were compounded using expired components.
Consumers who possess these specific lots of Tadalafil 20 mg Troche should stop using the product and contact the recalling firm or their healthcare provider for instructions on how to return or dispose of the medication.
The recalled product
- Product
- Tadalafil 20 mg Troche
- Manufacturer
- MPRX, Inc. dba Medical Park Pharmacy
- Category
- Drug — Compounded Medication
- Affected units
- 9
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: 61137:42 Use by: 03/08/2020
- 61324:99 Use by: 04/04/2020
- 60856:42 Use by: 02/02/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 18 recalled by MPRX, Inc. dba Medical Park Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · MPRX, Inc. dba Medical Park Pharmacy
See all →- ModerateProgesterone 50 mg Capsules Recalled for Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Naltrexone Capsules Due to Labeling Errors
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Lidocaine/Prilocaine Cream Due to Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Finasteride/Biotin Due to Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Liothyronine Due to Expired Components
FDA (Drugs) · 2020-02-05
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModeratePrescription Tadalafil tablets recalled for manufacturing process deviations
FDA (Drugs) · 2023-04-12
- HighTadalafil Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08
- ModerateTadalafil Tablets 20 mg recalled due to manufacturing deviations
FDA (Drugs) · 2023-05-03
- ModerateMasterPharm Recalls Vardenafil Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Sildenafil Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- HighFDA Recalls Tadalafil Tablets Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08